Cargando…

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

OBJECTIVE: To determine whether use of dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are associated with an increased risk of cholangiocarcinoma in adults with type 2 diabetes. DESIGN: Population based cohort study. SETTING: General practices contrib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abrahami, Devin, Douros, Antonios, Yin, Hui, Yu, Oriana HY, Faillie, Jean-Luc, Montastruc, François, Platt, Robert W, Bouganim, Nathaniel, Azoulay, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278586/ https://www.ncbi.nlm.nih.gov/pubmed/30518618 http://dx.doi.org/10.1136/bmj.k4880

Ejemplares similares

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
por: Abrahami, Devin, et al.
Publicado: (2018)

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014)

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
por: Ueda, Peter, et al.
Publicado: (2021)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
por: Azoulay, Laurent, et al.
Publicado: (2016)

Response by Abrahami et al to letter regarding article ‘Proton pump inhibitors and risk of colorectal cancer’
por: Abrahami, Devin, et al.
Publicado: (2022)

Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study
por: Abrahami, Devin, et al.
Publicado: (2020)

The use of drugs acting on the renin–angiotensin system and the incidence of pancreatic cancer
por: Mandilaras, Victoria, et al.
Publicado: (2017)

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

Evaluation of the quality of mammographic breast positioning: a quality improvement study
por: Rouette, Julie, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2023)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression
por: KHALAF, DANIEL, et al.
Publicado: (2014)

A66 PROTON PUMP INHIBITORS AND THE RISK OF INFLAMMATORY BOWEL DISEASE: A REAL WORLD POPULATION-BASED COHORT STUDY
por: Yanofsky, R P, et al.
Publicado: (2023)

Pancreatitis Associated With Incretin-Based Therapies
por: Iyer, Shridhar N., et al.
Publicado: (2013)

Socioeconomic aspects of incretin-based therapy
por: Karagiannis, Thomas, et al.
Publicado: (2023)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2022)

An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
por: Chon, Suk, et al.
Publicado: (2016)

Incretin-Based Therapies: Viewpoints on the way to consensus
por: Nauck, Michael. A., et al.
Publicado: (2009)

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Impact of Incretin-Based Medications on Lipid Metabolism
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Cardiovascular safety trials of incretin‐based drugs: What do they mean?
por: Yabe, Daisuke, et al.
Publicado: (2016)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
por: Mima, Akira
Publicado: (2016)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022)

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016)

A Case of Recurrent Anaplastic Meningioma of the Skull Base with Radiologic Response to Hydroxyurea
por: Gurberg, Joshua, et al.
Publicado: (2014)

Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control
por: Douros, Jonathan D., et al.
Publicado: (2019)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

The cardiovascular safety of incretin-based therapies: a review of the evidence
por: Petrie, John R
Publicado: (2013)

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies
por: Gerich, John
Publicado: (2013)

Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
por: Cho, Young Min
Publicado: (2015)

Uncertainties around incretin-based therapies: A literature review
por: Al Tulaihi, Bader, et al.
Publicado: (2017)

Incretin-based therapies in 2021 – Current status and perspectives for the future
por: Rizzo, Manfredi, et al.
Publicado: (2021)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31jke5i6urn0at597d8ae7intm